JY
PMVP icon

Jeff Yass’s PMV Pharmaceuticals PMVP Stock Holding History

Jeff Yass’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,900
Closed -$105K – 13090
2023
Q4 		$105K Sell
33,900
-250,400
-88% -$663K ﹤0.01% 11290
2023
Q3 		$1.75M Buy
284,300
+266,700
+1,515% +$1.83M ﹤0.01% 5410
2023
Q2 		$110K Sell
17,600
-15,800
-47% -$82.8K ﹤0.01% 10886
2023
Q1 		$159K Sell
33,400
-74,300
-69% -$523K ﹤0.01% 10857
2022
Q4 		$937K Buy
107,700
+76,400
+244% +$814K ﹤0.01% 6341
2022
Q3 		$372K Sell
31,300
-11,900
-28% -$172K ﹤0.01% 9254
2022
Q2 		$616K Sell
43,200
-24,400
-36% -$355K ﹤0.01% 7746
2022
Q1 		$1.41M Buy
+67,600
New +$1.19M ﹤0.01% 6298

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Jeff Yass's PMVP Position: Q2 2026 in Review

Jeff Yass opened a new position in PMV Pharmaceuticals (PMVP) in Q2 2026: 37,531 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #12827 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PMVP as recently as Q4 2025.

Jeff Yass first reported a position in PMVP in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.63M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Jeff Yass held 37,531 shares of PMV Pharmaceuticals worth $50.3K as of Q2 2026.
  • PMV Pharmaceuticals was a new Jeff Yass position in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12827 holding.
  • Jeff Yass first reported a position in PMV Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • Jeff Yass's PMV Pharmaceuticals position peaked at $1.63M in Q1 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.